NetworkNewsBreaks – CytoDyn Inc. (CYDY) President and CEO Featured in Uptick Newswire’s Stock Day Podcast

Biotechnology company CytoDyn (OTCQB: CYDY) this morning announced the featured interview of its President and CEO Nader Z. Pourhassan, Ph.D. with Stock Day’s Everett Jolly. Jolly initiated the discussion by asking about CytoDyn’s PRO 140. The company’s flagship product is a humanized IgG4 monoclonal antibody that is designed to bind to cellular receptor CCR5, which plays various roles with implications in HIV, tumor metastasis and immune signaling. Pending FDA approval, which the company hopes to secure in Q4 2019, Pourhassan indicates that PRO 140 may be available to the public in 2020.  “Most biotech companies, when they finish the biologic application, they have an 85% chance to get approved. 9 out of 10 who don’t get approved is because of the safety of the product. Our product has received fast track designation due to having great safety among all of the approved drugs,” Nader Z. Pourhassan, Ph.D., president and CEO of CytoDyn, stated in the news release.

To hear the Stock Day Podcast featuring the interview, visit http://nnw.fm/kYJU8

To view the full press release, visit http://nnw.fm/4Q7xo

About CytoDyn

CytoDyn is a biotechnology company developing innovative treatments for multiple therapeutic indications based on PRO 140 (leronlimab), a novel humanized monoclonal antibody targeting the CCR5 receptor. CCR5 plays a key role in the ability of HIV to enter and infect healthy T-cells.  The CCR5 receptor is also implicated in tumor metastasis and in immune-mediated illnesses such as graft-vs-host disease (GvHD) and NASH. CytoDyn has successfully completed a Phase 3 pivotal trial with PRO 140 in combination with standard anti-retroviral therapies in HIV-infected treatment-experienced patients. The Company plans to seek FDA approval for PRO 140 in combination therapy and plans to complete the filing of a Biological License Application (BLA) in the first quarter of 2019 for that indication. CytoDyn is also conducting a Phase 3 investigative trial with PRO 140 as a once-weekly monotherapy for HIV-infected patients, and plans to initiate a registration-directed study of PRO 140 monotherapy indication, which if successful, could support a label extension. Clinical results to date from multiple trials have shown that PRO 140 can significantly reduce viral burden in people infected with HIV with no reported drug-related serious adverse events (SAEs). Moreover, results from a Phase 2b clinical trial demonstrated that PRO 140 monotherapy can prevent viral escape in HIV-infected patients, with some patients on PRO 140 monotherapy remaining virally suppressed for more than four years. CytoDyn is also conducting a Phase 2 trial to evaluate PRO 140 for the prevention of GvHD and expects to initiate clinical trials with PRO 140 in metastatic triple-negative breast cancer in 2018. For more information, visit the company’s website at www.CytoDyn.com

More from NetworkNewsBreaks

NetworkNewsBreaks – Net Element, Inc. (NASDAQ: NETE) Launches Comprehensive POS Solution, Aptito NetworkNewsBreaks – Foresight Autonomous Holdings Ltd.’s (NASDAQ: FRSX) (TASE: FRSX) QuadSight Wins 2019 CES Innovation Award NetworkNewsBreaks – Plus Products Inc. (CSE: PLUS) Brings to Market its Cranberry & Shortbread Gummies: 2018 Holiday Limited Edition

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire has received compensation from CytoDyn Inc. for providing certain investor relations, marketing and social media services, including the preparation of this report, and expects to receive additional compensation for such services in the future. This compensation includes a monthly program fee.

More News From Biz Daily Online

Asian shares decline as China reports slowdown in exports

Jan 16, 2019

BANGKOK — Shares were lower in Asia on Monday, extending the latest losses on Wall Street, as China reported a slowdown in exports. KEEPING SCORE: Hong Kong's Hang Seng index lost 1.4 percent to 26,299.19 while the Shanghai Composite fell 0.6 percent to 2,539.59. The Kospi in South Korea declined 0.7 percent to 2,061.25 and Australia's S&P ASX 200 gave up 0.3 percent to 5,757.50. India's Sensex dropped 0.6 percent to 35,801.95. Shares also fell in Taiwan and Southeast Asia. Japan's markets were closed for a holiday. CHINA TRADE: China said Monday that its exports to the U.S. contracted in...

Asian shares rally on hopes for China-US trade breakthrough

Jan 16, 2019

BANGKOK — Shares extended gains in Asia on hopes for progress in resolving the tariffs battle between the U.S. and China as talks appeared to have been extended in Beijing. KEEPING SCORE: Japan's Nikkei 225 index gained 1.3 percent to 20,472.79 and Hong Kong's Hang Seng jumped 2.5 percent to 26,512.06. The Shanghai Composite index surged 1.6 percent to 2,566.66 while South Korea's Kospi advanced 1.9 percent to 2,062.64. Australia's S&P ASX 200 surged 0.9 percent to 5,775.20. Shares also rose in Taiwan and Southeast Asia. CHINA-US TRADE: President Donald Trump tweeted that "Talks with China are going very well!"...

Asian shares mixed amid silence on China-US trade talks

Jan 16, 2019

BANGKOK — Shares were mixed in Asia on Tuesday as officials kept silent on talks in Beijing aimed at resolving trade tensions with the U.S. KEEPING SCORE: Japan's Nikkei 225 index gained 1.1 percent to 20,251.42 and the Hang Seng in Hong Kong added 0.3 percent to 25,905.82. Australia's S&P ASX 200 gained 0.6 percent to 5,716.90 and the South Korean Kospi gave up 0.2 percent to 2,033.62. Shares fell in Taiwan and Thailand but rose in Singapore and Indonesia. WALL STREET: Stocks extended gains Monday, lifted by buying of retailers and smaller companies after a report showed strong orders...

Stocks start 2019 on back foot after weak Chinese data

Jan 16, 2019

BEIJING — Stock markets started the new year with a tumble, as disappointing Chinese economic data on Wednesday renewed concerns that a global trade war is weighing on growth. KEEPING SCORE: In Europe, France's CAC 40 fell 1.6 percent to 4,653 and Germany's DAX retreated 0.2 percent to 10,531. Both had opened with losses in excess of 2 percent and 1 percent, respectively. London's FTSE 100 was down 0.9 percent to 6,667. On Wall Street, futures for the Standard & Poor's 500 and for the Dow Jones Industrial Average were both down 1.4 percent. ASIA'S DAY: The Shanghai Composite Index...

Asian stocks skid after weak China factory readings

Jan 16, 2019

BEIJING — Asian stock markets tumbled Wednesday as 2019 trading began, after surveys showed Chinese manufacturing weakening. KEEPING SCORE: The Shanghai Composite Index lost 1.1 percent to 2,465.29 and Hong Kong's Hang Seng fell 2.6 percent to 25,161.03. Japan's markets were closed. Seoul's Kospi lost 1.3 percent to 2,013.80 and Sydney's S&P-ASX 200 shed 0.9 percent to 5,593.80. Manila advanced while Singapore and Jakarta retreated. New Zealand was closed. CHINESE FACTORIES: Surveys by China's government and a major business magazine showed activity weakened in December as global and domestic demand cooled. Forecasters said that could send shockwaves through Asian economies...

About Us

Biz Daily Online gives a complete understanding of the world of business to you. Get today’s business news and learn about the trends that are affecting every business here.

Contact us: sales[at]bizdailyonline.com

Subscribe Now!